VDRM (ViaDerma) Cash And Cash Equivalents : $1.19 Mil (As of Jun. 2012)

View and export this data going back to 2008. Start your Free Trial

What is ViaDerma Cash And Cash Equivalents?

ViaDerma's quarterly cash and cash equivalents increased from Dec. 2011 ($0.58 Mil) to Mar. 2012 ($1.37 Mil) but then stayed the same from Mar. 2012 ($1.37 Mil) to Jun. 2012 ($1.19 Mil).

ViaDerma's annual cash and cash equivalents increased from Dec. 2009 ($0.78 Mil) to Dec. 2010 ($0.97 Mil) but then declined from Dec. 2010 ($0.97 Mil) to Dec. 2011 ($0.58 Mil).

ViaDerma Cash And Cash Equivalents Historical Data

The historical data trend for ViaDerma's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ViaDerma Cash And Cash Equivalents Chart

ViaDerma Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Cash And Cash Equivalents

0.27

0.78

0.97

0.58

ViaDerma Quarterly Data
	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12
Cash And Cash Equivalents	Get a 7-Day Free Trial															0.75	0.30	0.58	1.37	1.19

ViaDerma Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

ViaDerma (OTCPK:VDRM) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

ViaDerma Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of ViaDerma's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

ViaDerma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ViaDerma Inc (OTCPK:VDRM) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

4640 Admiralty Way, Suite 500, Marina Del Rey, CA, USA, 90292

Website

https://www.viaderma.com

ViaDerma Inc is a specialty pharmaceutical company focused to bring new products to market through research and development. It is engaged in the business of manufacturing and sales of pharmaceuticals, and specifically topical antibiotics and pain management in the United States of America. Its sells under the brand name Vitastem. The Company also has products in development in the fields; anti-aging skin care, pain management, hair-loss, and toenail fungus.